Skip to main content

Find Clinical Trials

Home
Conditions
Inflammation

Clinical trial condition

Inflammation

Explore clinical trials studying Inflammation. Study availability and eligibility vary by location and protocol.

2,798 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Inflammation trial results

Completed

A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

NCT00042588

Conditions: Community-Acquired Infections, Community-Acquired Pneumonia, Infections, +9 more
Locations: ICOS Corporation Bothell, Washington, United States

View Trial Details

Completed

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

NCT00002192

Conditions: AIDS-Related Opportunistic Infections, Actinomycetales Infections, Bacteremia, +27 more
Locations: Hampton Roads Med Specialists Hampton, Virginia, United States

View Trial Details

Terminated

Adult MDW Dual Cut-Off Accuracy Study

NCT06885528

Conditions: Infections, Inflammation, Pathologic Processes, +3 more
Locations: Indiana University Indianapolis, Indiana, United States

Kansas University Medical Center Kansas City, Kansas, United States

Henry Ford Health System Detroit, Michigan, United States

Truman Medical Center Kansas City, Missouri, United States

View Trial Details

Terminated

Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients

NCT06075888

Conditions: Agranulocytosis, Bacteremia, Bacterial Infections, +22 more
Locations: C.H.U. d'Angers Angers, France

CHU de Brest Brest, France

C.H.U. de Limoges Limoges, France

C.H.U. de Poitiers Poitiers, France

View Trial Details

Terminated

Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study

NCT02417168

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: CAMC Health Systems Charleston, West Virginia, United States

View Trial Details

Terminated

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

NCT05178862

Conditions: Bacterial Infections and Mycoses, Candidemia, Candidiasis, +10 more
Locations: University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States

Banner University Medical Center-Tucson Tucson, Arizona, United States

UC Davis Medical Center Sacramento, California, United States

UCSF School of Medicine San Francisco, California, United States

View all 101 locations

View Trial Details

Withdrawn

Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis

NCT00368381

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Endocrine System Diseases, +7 more
Locations: Not specified

View Trial Details

Withdrawn

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06703216

Conditions: B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details